Neuropsychiatric Disorders in Cushing's Syndrome

被引:109
作者
Pereira, Alberto M. [1 ]
Tiemensma, Jitske [1 ]
Romijn, Johannes A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands
关键词
Cushing's syndrome; Treatment; Depression; Mania; Psychopathology; QUALITY-OF-LIFE; PITUITARY-ADENOMAS; DISEASE; PERSONALITY; CORTISOL; PSYCHOPATHOLOGY; MANIFESTATIONS; DEPRESSION; CURE;
D O I
10.1159/000314317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids are crucial in the initiation and consolidation of the stress response. Patients with active Cushing's syndrome (CS) are exposed to excessive endogenous glucocorticoid levels. In these patients, psychopathology is often being observed. The most common co-morbid disorder is major depression, but to a lesser extent mania and anxiety disorders have also been reported. A severe clinical presentation of CS often also includes depression. Reduction of glucocorticoid synthesis or action, either with metyrapone, ketoconazole, or mifepristone, rather than treatment with antidepressant drugs, is generally successful in relieving depressive symptoms, as well as other disabling symptoms. Following successful surgical treatment of hypercortisolism, both physical and psychiatric signs and symptoms improve substantially. However, it appears that patients do not completely return to their premorbid level of functioning and persistent impairment of quality of life and cognitive function has been reported despite long-term cure. At present, it is not clear whether, and to which extent, psychopathology still affects general well-being after long-term cure of CS. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
  • [31] Glucose metabolism in Cushing's syndrome
    Sharma, Anu
    Vella, Adrian
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2020, 27 (03) : 140 - 145
  • [32] Cushing's syndrome: Aftermath of the cure
    Pivonello, Rosario
    De Martino, Maria Costina
    De Leo, Monica
    Tauchmanova, Libuse
    Faggiano, Antongiulio
    Lombardi, Gaetano
    Colao, Annamaria
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (08) : 1381 - 1391
  • [33] Quality of life impairment after a diagnosis of Cushing's syndrome
    Webb, Susan M.
    Valassi, Elena
    [J]. PITUITARY, 2022, 25 (05) : 768 - 771
  • [34] Pharmacological management of severe Cushing's syndrome: the role of etomidate
    Pence, Andrea
    McGrath, Megan
    Lee, Stephanie L.
    Raines, Douglas E.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [35] Cushing's syndrome
    Newell-Price, John
    [J]. CLINICAL MEDICINE, 2008, 8 (02) : 204 - 208
  • [36] Disease Activity is Associated with Depression and Anxiety in Cushing's Syndrome During COVID-19 Pandemic
    Piskinpasa, Hamide
    Turgut, Seda
    Karaarslan, Ozlem
    Bozkur, Evin
    Esen, Ayse
    Pamuk, Naim
    Cakir, Ilkay
    Mert, Meral
    Dogansen, Sema Ciftci
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 25 (02) : 166 - 173
  • [37] Structural brain abnormalities in Cushing's syndrome
    Bauduin, Stephanie E. E. C.
    van der Wee, Nic J. A.
    van der Werff, Steven J. A.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2018, 25 (04) : 285 - 289
  • [38] THE USE OF MIFEPRISTONE IN THE TREATMENT OF CUSHING'S SYNDROME
    Carroll, T.
    Findling, J. W.
    [J]. DRUGS OF TODAY, 2012, 48 (08) : 509 - 518
  • [39] Diagnosis of Cushing's Syndrome in the Modern Era
    Nieman, Lynnette Kaye
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (02) : 259 - +
  • [40] Telomere length analysis in Cushing's syndrome
    Aulinas, Anna
    Ramirez, Maria-Jose
    Barahona, Maria-Jose
    Valassi, Elena
    Resmini, Eugenia
    Mato, Eugenia
    Santos, Alicia
    Crespo, Iris
    Bell, Olga
    Surralles, Jordi
    Webb, Susan M.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (01) : 21 - 29